Roche drops $1.85B for GenMark's testing tech as pandemic, antibiotic resistance threats loom

Roche has only played a minor role in the hunt for Covid-19 drugs and vaccines. Instead, the Swiss giant made their influence in a field in which most of their rivals now play only bit parts: diagnostics. Three different Roche tests won a Covid-19 EUA over the past year.

Now, they’re adding a slate of new tools to their testing arsenal, buying out GenMark Diagnostics for $1.85 billion.